Euclid Technologies LLC is the leading IT consulting firm specializing in the pharmaceutical industry. When decision makers need assistance with major business challenges, they rely on us—a true strategic partner focused on their industry and their needs.
Euclid Technologies LLC is an international consultancy providing a full range of independent GCP, GLP and GMP Quality Assurance ,Business Analysis and GPVP services on a global basis.
Studies, service providers and systems are audited against international and national standards, namely ICH GCP, the Clinical Trial Directive 2001/20/EC, GCP Directive 2005/28/EC and FDA 21 CFR. All of our Consultants carry professional indemnity insurance.
In addition, Euclid Technologies LLC provides advice and training on all aspects of ICH GCP, the Clinical Trial Directive 2001/20/EC, GCP Directive 2005/28/EC and FDA 21 CFR.
It also provides a comprehensive Computer System Validation (CSV) audit service in all stages of the life cycle of a computerised system. The CSV audit assesses good computer system management practice, and verifies that the computerised system is validated according to regulatory requirements such as 21 CFR part 11 and ICH GCP. Euclid Technologies LLC provides a positive and pragmatic service that is of optimum benefit to the auditee.
The mission of ADAMAS Consulting is to be the independent global service provider of choice for Clinical Quality Assurance, Quality Management and Specialised Training to the Pharmaceutical, Biotechnology, Medical Devices and related industries through:
- Having the vision, experience and understanding of our clients' needs to assist them in meeting their business goals
- Recruiting, training and developing high calibre professionals
- Commitment to the highest standards of excellence, integrity and performance
Business Development
The Business Development practice helps clients improve their decision-making capabilities—and move more quickly—in today's competitive licensing environment. Business development is more important—and more competitive—than ever. To make the right deals at the right times, you must be plugged in to what's happening in the market. You have to locate the opportunities and make sound decisions quickly. Our Business Development practice is extremely well-networked. We know what's going on and who the players are. We also offer the knowledge you need to properly assess opportunities and make the right decisions.
Euclid Technologies LLC consultants provide experienced counsel to clients who need assistance developing business development strategies, identifying partners, prioritizing targets, evaluating opportunities, and negotiating deals.
Our team members are seasoned professionals in pharmaceutical and biotech business development. As consultants and industry professionals, they’ve identified, assessed, and executed numerous in-licensing deals, assisted out-licensors, helped clients improve internal processes for pharmaceutical business development, and helped top executives chart new strategies in corporate development.
The following outlines our Business Development practice's service offerings:
Strategy Development
Business Model Development
- Design business models
- Develop strategies for entering new geographic markets
Portfolio Strategy Development
- Assess pipeline and portfolio gaps
- Identify and prioritize therapeutic areas and disease state targets
- Formulate portfolio strategies and outline how to leverage BD to meet them
Transaction Support
Corporate Transaction Support
- Conduct or assist with acquisition due diligence
- Help clients prepare for sale
Product Transaction Support
- Provide expert support with in-licensing efforts
- Identify in-licensing opportunities that meet strategic criteria
- Screen in-licensing opportunities
- Validate selection of in-licensing candidates
- Assess the potential commercial value of in-licensing candidates
- Formulate offers and alternatives
- Provide expert support with out-licensing efforts
- Define out-licensing objectives and strategies
- Identify potential partners
- Develop dossiers for products being considered for out-licensing
- Develop or improve BD materials to present the client company as an attractive potential partner
